HK Stock Market Move | LAUNCH TECH (02488) rose over 4% after earnings, with mid-term revenue approximately 1.071 billion yuan and rapid growth in revenue from its new energy equipment.
Yuanheng Technology (02488) rose over 4% after its results announcement, reaching an increase of 4.07% at 7.155 Hong Kong dollars, with a transaction volume of 3.1229 million Hong Kong dollars as of the time of writing.
LAUNCH TECH (02488) rose over 4% after its performance announcement, with a current increase of 4.07%, priced at HKD 7.155, with a trading volume of HKD 3.1229 million.
On August 10, LAUNCH TECH released its interim results for 2026, reporting an operating revenue of approximately RMB 1.071 billion, an increase of 9.1% year-on-year; a net profit attributable to shareholders of approximately RMB 175 million; basic earnings per share of RMB 0.426; and a distribution of an interim dividend of RMB 0.29 per share. The announcement stated that in the first half of 2026, the group maintained a growth trend under pressure, achieving operating revenue of about RMB 1.07 billion, a year-on-year growth of 9.1%, and main business revenue of approximately RMB 1.05 billion, up 9.5%; gross profit reached around RMB 500 million, an increase of 5.2%; and the net profit attributable to shareholders was about RMB 175 million.
On the product side, the companys X-431 series smart diagnostic equipment achieved sales of approximately 169,000 units in the first half of 2026, rising by about 4.8% year-on-year. In the face of pressures from the decline of overseas customers temporary stockpiling, this product remains a core hardware foundation for the group, continuously providing vast terminal access for value-added services such as software subscriptions, remote diagnostics, AI intelligent services, and big data; the new energy equipment is accelerating its global layout relying on Yuan Zheng's new energy stations, with 165 sites established worldwide, covering 15 cities in China and 5 countries overseas, and the revenue from new energy equipment is rapidly increasing.
Related Articles
.png)
IMPRO PRECISION (01286) announced its mid-year results for 2026, reporting a profit attributable to shareholders of HKD 421 million, a year-on-year increase of 21.6%.

CHINA TOWER (00788) released its mid-term performance report for 2026, with a net profit attributable to shareholders of 7.489 billion yuan, an increase of 30.1% year-on-year.

HK Stock Market Move | BOAN BIOTECH (06955) rose more than 3% in the morning. Recently, the application for market authorization of Aflibercept intravitreal injection has been submitted in Brazil.
IMPRO PRECISION (01286) announced its mid-year results for 2026, reporting a profit attributable to shareholders of HKD 421 million, a year-on-year increase of 21.6%.
.png)
CHINA TOWER (00788) released its mid-term performance report for 2026, with a net profit attributable to shareholders of 7.489 billion yuan, an increase of 30.1% year-on-year.

HK Stock Market Move | BOAN BIOTECH (06955) rose more than 3% in the morning. Recently, the application for market authorization of Aflibercept intravitreal injection has been submitted in Brazil.

RECOMMEND





